Abstract
Strained ruthenium (Ru) complexes have been synthesized and characterized as novel agents for photodynamic therapy (PDT). The complexes are inert until triggered by visible light, which induces ligand loss and covalent modification of DNA. An increase in cytotoxicity of 2 orders of magnitude is observed with light activation in cancer cells, and the compounds display potencies superior to cisplatin against 3D tumor spheroids. The use of intramolecular strain may be applied as a general paradigm to develop light-activated ruthenium complexes for PDT applications.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Electronic Coupling between Two Cyclometalated Ruthenium Centers Bridged by 1,3,6,8-Tetra(2-pyridyl)pyrene (tppyr)
A new cyclometalating bridging ligand 1,3,6,8-tetra(2-pyridyl)pyrene was designed and synthesized through 4-fold Suzuki couplings between 1,3,6,8-tetrabromopyrene and 2-pyridylb...
A rapid capsaicin-activated current in rat trigeminal ganglion neurons.
A subpopulation of pain fibers are activated by capsaicin, the ingredient in red peppers that produces a burning sensation when eaten or placed on skin. Previous studies on dors...
Ruthenium red blocks the capsaicin-induced increase in intracellular calcium and activation of membrane currents in sensory neurones as well as the activation of peripheral nociceptors in vitro
In a number of sensory neuron preparations, Ruthenium red (RR) selectively attenuated the response to capsaicin. First, RR (100 nM) reversibly abolished capsaicin but not bradyk...
Publication Info
- Year
- 2012
- Type
- article
- Volume
- 134
- Issue
- 20
- Pages
- 8324-8327
- Citations
- 485
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1021/ja3009677
- PMID
- 22553960